Liver biopsy is a superior diagnostic method in some patients showing the typical laboratory features of autoimmune hepatitis

Clinics and Research in Hepatology and Gastroenterology

Volumn 36, Issue 2, 2012, Pages 185-188

  Efe, Cumali ^a   Ozaslan, Ersan ^b   Purnak, Tugrul ^b   Ozseker, Burak ^a   Kav, Taylan ^a   Bayraktar, Yusuf ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Numune Research and Education Hospital ^*  (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; IMMUNOGLOBULIN G; SMOOTH MUSCLE ANTIBODY;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMOCHROMATOSIS; HUMAN; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; TOXIC HEPATITIS; WILSON DISEASE;

ADULT; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER; LIVER DISEASES; MALE; RETROSPECTIVE STUDIES;

EID: 84858624311     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.08.011     Document Type: Article

References (14)

1. Krawitt E.L. Autoimmune hepatitis. N Engl J Med 2006, 354:54-66.
2. Manns M.P., Czaja A.J., Gorham J.D., et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010, 51:2193-2213.
3. Hennes E.M., Zeniya M., Czaja A.J., et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008, 48:169-176.
4. Björnsson E., Talwalkar J., Treeparsertsuk S., et al. Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis. Clin Gastroenterol Hepatol 2011, 9:57-63.
5. Yatsuji S., Hashimoto E., Kaneda H., et al. Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful?. J Gastroenterol 2005, 40:1130-1138.
6. Cotler S.J., Kanji K., Keshavarzian A., et al. Prevalence and significance of autoantibodies in patients with non-alcoholic steatohepatitis. J Clin Gastroenterol 2004, 38:801-804.
7. Adams L.A., Lindor K.D., Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with nonalcoholic fatty liver disease. Am J Gastroenterol 2004, 99:1316-1320.
8. Invernizzi P., Selmi C., Gershwin M.E. Update on primary biliary cirrhosis. Dig Liver Dis 2010, 42:401-408.
9. Lindor K.D., Gershwin M.E., Poupon R., et al. Primary biliary cirrhosis. Hepatology 2009, 50:291-308.
10. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol 2010, 52:745-758.
11. Czaja A.J. Drug-induced autoimmune-like hepatitis. Dig Dis Sci 2011, 56:958-976.
12. Bjornsson E., Talwalkar J., Treeprasertsuk S., et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology 2010, 51:2040-2048.
13. Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis vs. drug-induced liver injury. Hepatology. 2011. doi:10.1002/hep.24481.
14. Weiler-Normann C, Schramm C. Drug induced liver injury and its relationship to autoimmune hepatitis. J Hepatol. 2011. doi:10.1016/j.jhep.2011.02.024.